Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Bunse, Mario Dr. (1) Kammertöns, Thomas Dr. (1) Kieback, Elisa Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (1) Uckert, Wolfgang Prof. Dr. (2) (-) Blankenstein, Thomas Prof. Dr. (10) (-) Molekulare Immunologie und Gentherapie (10) 1992 (4) 1993 (7) 1994 (5) 1995 (8) (-) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2006 (1) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) 2013 (11) 2014 (3) 2015 (3) (-) 2016 (4) 2017 (6) 2018 (5) 2019 (6) 2021 (4) 2022 (6) 2023 (4) 2024 (2) 10 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Molekulare Immunologie und Gentherapie 19962016 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Januar 1996 / Hum Gene Ther Coexpression of interleukin-4 and B7.1 in murine tumor cells leads to improved tumor rejection and vaccine effect compared to single gene transfectants and a classical adjuvant S. Cayeux C. Beck B. Doerken T. Blankenstein 01. Januar 1996 / Curr Top Microbiol Immunol The influence of local cytokines on tumor metastasis: using cytokine gene transfected tumor cells as experimental models Z. Qin T. Blankenstein 01. Januar 1996 / Rev Physiol Biochem Pharmacol Genetic approaches to cancer immunotherapy T. Blankenstein S. Cayeux Z. Qin 01. Januar 1996 / Nature Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein S. Brocke K. Gijbels M. Allegretta I. Ferber C. Piercy T. Blankenstein R. Martin U. Utz N. Karin D. Mitchell T. Veromaa A. Waisman A. Gaur P. Conlon N. Ling P.J. Fairchild D.C. Wraith A. Ogarra C.G. Fathman L. Steinman 01. Januar 1996 / Gene Ther Cancer vaccines in gene therapy T. Blankenstein Z. Qin 01. Januar 1996 / Eur J Immunol Attenuation of collagen induced-arthritis in mice by treatment with vector cells engineered to secrete interleukin-13 N. Bessis M.C. Boissie P. Ferrara T. Blankenstein D. Fradelizi C. Fournier 17. Oktober 2016 / J Exp Med Preventing tumor escape by targeting a post-proteasomal trimming independent epitope A. Textor K. Schmidt P.M. Kloetzel B. Weißbrich C. Perez J. Charo K. Anders J. Sidney A. Sette T.N.M. Schumacher C. Keller D.H. Busch U. Seifert T. Blankenstein 01. März 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein 22. Juli 2016 / PLoS ONE Interleukin-7 modulates anti-tumor CD8+ T cell responses via its action on host cells K. Deiser D. Stoycheva U. Bank T. Blankenstein T. Schüler 07. April 2016 / Nat Biotechnol Receptor combinations hone T-cell therapy T. Blankenstein
01. Januar 1996 / Hum Gene Ther Coexpression of interleukin-4 and B7.1 in murine tumor cells leads to improved tumor rejection and vaccine effect compared to single gene transfectants and a classical adjuvant S. Cayeux C. Beck B. Doerken T. Blankenstein
01. Januar 1996 / Curr Top Microbiol Immunol The influence of local cytokines on tumor metastasis: using cytokine gene transfected tumor cells as experimental models Z. Qin T. Blankenstein
01. Januar 1996 / Rev Physiol Biochem Pharmacol Genetic approaches to cancer immunotherapy T. Blankenstein S. Cayeux Z. Qin
01. Januar 1996 / Nature Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein S. Brocke K. Gijbels M. Allegretta I. Ferber C. Piercy T. Blankenstein R. Martin U. Utz N. Karin D. Mitchell T. Veromaa A. Waisman A. Gaur P. Conlon N. Ling P.J. Fairchild D.C. Wraith A. Ogarra C.G. Fathman L. Steinman
01. Januar 1996 / Eur J Immunol Attenuation of collagen induced-arthritis in mice by treatment with vector cells engineered to secrete interleukin-13 N. Bessis M.C. Boissie P. Ferrara T. Blankenstein D. Fradelizi C. Fournier
17. Oktober 2016 / J Exp Med Preventing tumor escape by targeting a post-proteasomal trimming independent epitope A. Textor K. Schmidt P.M. Kloetzel B. Weißbrich C. Perez J. Charo K. Anders J. Sidney A. Sette T.N.M. Schumacher C. Keller D.H. Busch U. Seifert T. Blankenstein
01. März 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein
22. Juli 2016 / PLoS ONE Interleukin-7 modulates anti-tumor CD8+ T cell responses via its action on host cells K. Deiser D. Stoycheva U. Bank T. Blankenstein T. Schüler